## **Core Concept**
Nocardia asteroides is a type of aerobic actinomycete that is known to cause infections, particularly in immunocompromised individuals. It is commonly found in soil and can cause a range of diseases, from cutaneous infections to systemic diseases like nocardiosis. Nocardia infections are characterized by their ability to cause abscesses and their partial resistance to many antibiotics.

## **Why the Correct Answer is Right**
The correct answer, **C. Pneumonia in immunocompromised patients**, is right because Nocardia asteroides is particularly known for causing pulmonary infections, especially in individuals with compromised immune systems, such as those with HIV/AIDS, undergoing chemotherapy, or on long-term corticosteroid therapy. The organism can cause severe pneumonia, which may disseminate to other parts of the body, including the brain, where it can form abscesses.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While Nocardia can cause skin infections, stating it as a characteristic infection without specifying the population or the common presentation of pulmonary or disseminated disease makes it less accurate.
- **Option B:** This option is too broad and does not specifically relate to Nocardia asteroides infections. Many pathogens cause brain abscesses, and this is not unique or characteristic enough for Nocardia.
- **Option D:** This option refers to a condition caused by *Mycobacterium avium* complex (MAC), which is more commonly associated with infections in immunocompromised patients, particularly those with advanced HIV infection.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Nocardia infections are often associated with immunocompromised states and can cause a variety of clinical syndromes, most notably pulmonary nocardiosis. A classic clinical clue is that Nocardia infections do not respond to typical antibiotics used for common bacterial infections but are often treated with trimethoprim-sulfamethoxazole.

## **Correct Answer:** C. Pneumonia in immunocompromised patients